Early signs of damage to the brain as a target organ in hypertension
https://doi.org/10.14412/2074-2711-2019-3S-32-37
Abstract
The paper reviews the data available in the literature on and the results of the authors' own investigations of the signs of brain damage in hypertension in its early stages. The signs of early brain damage in hypertension can be considered as deteriorated control functions, white matter hyperintensities (WMH), as evidenced by the standard modes of magnetic resonance imaging (MRI), decreased fractional anisotropy in the frontal lobes, as shown by diffusion tensor MRI, and reduced cerebral perfusion. The latter two signs are detected even in hypertensive patients without WMH. Cognitive function testing and brain MRI using special regimens make it possible to identify a group of hypertensive patients at higher risk for cerebrovascular complications just in the early stages of the disease.
About the Authors
T. M. Ostroumova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991
O. D. Ostroumova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia;
Russian Research and Clinical Center of Gerontology, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991;
16, First Leonov St., Moscow 129226
V. A. Parfenov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991
References
1. Clinical guidelines. Diagnosis and treatment of arterial hypertension. Kardiologicheskij Vestnik. 2015;10(1):3-30 (In Russ.).
2. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940
3. Boytsov SA, Balanova YuA, Shalnova SA, et al. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2014; 13(4):4-14 (In Russ.). doi:10.15829/1728-8800-2014-4-4-14
4. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455): 217-23. doi: 10.1016/S0140-6736(05)17741-1
5. Musini VM, Gueyffier F, Puil L, et al. Pharmacotherapy for hypertension in adults aged 18 to 59 years. Cochrane Database Syst Rev. 2017;8:CD008276. doi: 10.1002/14651858. CD008276.pub2
6. Cui J, Yu R, Li M, et al. Intervention affects the cognitive performance of middle-aged patients with essential hypertension. Int J Clin Exp Med. 2016;9(1):308-15.
7. Shehab A, Abdulle A. Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension. BMC Cardiovasc Disord. 2011;11:3. doi: 10.1186/1471-2261-11-3
8. Parfenov VA, Ostroumova TM, Ostroumova OD, Pavleyva EE. Features of the clinical picture in patients of middle age with essential hypertension. Terapevticheskii Arkhiv. 2018;90(9):15-26 (In Russ.). doi: 10.26442/terarkh201890915-26
9. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol. 1987;44(1): 21-3. doi: 10.1001/archneur.1987.00520130013009
10. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: a united approach. Lancet Neurol. 2013;12(8):822-38. doi: 10.1016/S1474-4422(13)70124-8
11. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and metaanalysis. BMJ. 2010;341:c3666. doi: 10.1136/bmj.c3666
12. Sabayan B, van der Grond J, Westendorp RG, et al. Accelerated progression of white matter hyperintensities and subsequent risk of mortality: a 12-year follow-up study. Neurobiol Aging. 2015;36:2130-5. doi: 10.1016/j.neurobiolaging.2015.03.003
13. Sierra С, de la Sierra A, Mercader J, et al. Silent cerebral white matter lesions in middleaged essential hypertensive patients. J Hypertens. 2002;20(3):519-24. doi: 10.1097/00004872-200203000-00028
14. Ostroumova TM, Parfenov VA, Ostroumova OD, et al. Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):17-23 (In Russ.). doi: 10.14412/2074-2711-2018-1-17-23
15. Le Bihan D, van Zijl P. From the diffusion coefficient to the diffusion tensor. NMR Biomed. 2002;15(7-8):431-4. doi: 10.1002/nbm.798
16. Levashkina IM, Serebryakova SV, Efimcev AYu. Diffusion tensor MRI – the modern method of evaluation of microstructural changes in brain matter (literature review). Vestnik SPbGU. Meditsina = Vestnik St. Petersburg University. Medicine. 2016;(4):39-54 (In Russ.).
17. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161(2):401-7. doi: 10.1148/radiology.161.2.3763909
18. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105-16. doi: 10.1016/0895-4356(88)90080-7
19. Launer LJ, Lewis CE, Schreiner PJ, et al. Vascular factors and multiple measures of early brain health: CARDIA brain MRI study. PLoS One. 2015;10(3):e0122138. doi: 10.1371/journal.pone.0122138
20. Gons RA, de Laat KF, van Norden AGW, et al. Hypertension and cerebral diffusion tensor imaging in small vessel disease. Stroke. 2010;41(12): 2801-6. doi: 10.1161/STROKEAHA.110.597237
21. Parfenov VA, Ostroumova TM, Ostroumova OD, et al. Diffusion tensor magnetic resonance imaging in the diagnosis of white matter lesion in middle-aged patients with uncomplicated essential hypertension. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(2): 20-6 (In Russ.). doi: 10.14412/2074-2711-2018-2-20-26
22. Jones D, Lythgoe D, Horsfield M, et al. Characterization of white matter damage in ischaemic leukoaraiosis with diffusion tensor MRI. Stroke. 1999;30(2):393-7. doi: 10.1161/01.STR.30.2.393
23. Chabriat H, Pappata S, Poupon C, et al. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke. 1999;30(12): 2637-43. doi: 10.1161/01.STR.30.12.2637
24. Nitkunan A, Charlton RA, McIntyre DJ, et al. Diffusion tensor imaging and MR spectroscopy in hypertension and presumed cerebral small vessel disease. Magn Reson Med. 2008; 59(3):528-34. doi: 10.1002/mrm.21461
25. Rosano C, Abebe KZ, Aizenstein HJ, et al; Health ABC Study. Longitudinal systolic blood pressure characteristics and integrity of white matter tracts in a cohort of very old black and white adults. Am J Hypertens. 2015;28(3):326-34. doi: 10.1093/ajh/hpu134
26. Sierra C, Coca A. White Matter Lesions and Cognitive Impairment as Silent Cerebral Disease in Hypertension. Sci World J. 2006; 6:494-501. doi: 10.1100/tsw.2006.99
27. Pronin IN, Fadeeva LM, Podoprigora AE, et al. Arterial spin labeling (ASL) – method of visualization and evaluation of cerebral blood flow. Luchevaya Diagnostika i Terapiya = Radiation Diagnosis and Therapy. 2012;3(3): 64-78 (In Russ.).
28. Wang T, Li Y, Guo X, et al. Reduced perfusion in normal-appearing white matter in mild to moderate hypertension as revealed by 3D pseudocontinuous arterial spin labeling. J Magn Reson Imaging. 2016;43(3):635-43. doi: 10.1002/jmri.25023
Review
For citations:
Ostroumova T.M., Ostroumova O.D., Parfenov V.A. Early signs of damage to the brain as a target organ in hypertension. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):32-37. (In Russ.) https://doi.org/10.14412/2074-2711-2019-3S-32-37
Views: 700
Email this article 